⚠ Evidence warning: Clinical trials or other evidence do not support the claims that clove or eugenol works against metronidazole-resistant Giardia and against HSV-2, influenza and respiratory syncytial virus. This page keeps it as a report of what people, websites or other media say.

Clove Antimicrobial Spectrum

Antimicrobial Spectrum — scientific infographic poster

Eugenol's broad-spectrum antimicrobial activity is one of the most consistently replicated findings across the entire ethnopharmacology literature. Hundreds of in-vitro studies, spanning four decades and dozens of laboratories, have tested clove essential oil or purified eugenol against Gram-positive bacteria, Gram-negative bacteria, fungi (notably Candida species), parasites including the giardiasis pathogen Giardia lamblia, and enveloped viruses including herpes simplex types 1 and 2. The pattern is remarkably consistent: clinically significant inhibition at minimum inhibitory concentrations in the 0.1–5 mg/mL range — concentrations achievable in topical applications, oral rinses, food preservation matrices, and the upper gastrointestinal tract after oral dosing. The traditional use of clove as a heavy spice in equatorial cuisines (Indonesia, India, Southeast Asia, Sri Lanka) almost certainly evolved partly as a food preservation strategy in tropical climates where bacterial contamination is rapid. This deep-dive surveys the antimicrobial spectrum, the membrane-disruption mechanism, the traditional food-preservation use, and the rational basis for combining clove with other plant antimicrobials.


Table of Contents

  1. Eugenol and Tropical Food Preservation — The Indonesian/Indian Cuisine Connection
  2. Membrane Disruption — The Universal Mechanism
  3. Gram-Positive Bacteria — Staphylococcus, Streptococcus, Listeria
  4. Gram-Negative Bacteria — E. coli, Salmonella, Pseudomonas
  5. Anaerobic Pathogens — Clostridium, Bacteroides, Oral Anaerobes
  6. Candida and Other Fungi
  7. Parasites — Giardia, Entamoeba, and Other Protozoa
  8. Enveloped Viruses — HSV-1, HSV-2, Influenza, Respiratory Syncytial Virus
  9. Biofilm Disruption
  10. Food Preservation Applications
  11. Synergy with Other Antimicrobials
  12. Cautions and Practical Limits
  13. Key Research Papers
  14. Connections
  15. Featured Videos

Eugenol and Tropical Food Preservation — The Indonesian/Indian Cuisine Connection

The native range of Syzygium aromaticum is the Maluku Islands of eastern Indonesia, in the equatorial tropics where bacterial spoilage of food is rapid. Clove's history as a spice begins as a local food preservative, then spreads via the Maritime Silk Road to Indian, Persian, Arab, and eventually European cuisine. Heavily spiced Indonesian and Indian dishes — gulai, rendang, biryani, curries — combine clove with cinnamon, cardamom, black pepper, ginger, and other antimicrobially active spices in concentrations that produce meaningful eugenol exposure in the dish and meaningful antimicrobial activity against contaminating bacteria.

A 1999 paper by Sherman and Billing in the journal BioScience formalized what cuisine anthropologists had observed for decades: the tropical-region cuisines of the world systematically use more spices, in higher quantities, and with greater preference for antimicrobially active spices, than the cuisines of cooler climates. The biological hypothesis is that spice use evolved partly as an antimicrobial defense strategy, with cultures that used antimicrobial spices having lower rates of foodborne illness and therefore higher reproductive success. Clove is consistently among the spices showing the strongest correlation with this pattern.

The modern food science literature confirms the practical antimicrobial effect of clove in food matrices. Clove essential oil at 0.1–1% concentration extends the shelf life of meat, fish, dairy, and baked goods by inhibiting the growth of spoilage and pathogenic bacteria. The principal limitation is sensory — at concentrations sufficient for full antimicrobial effect, the eugenol flavor dominates the dish. This is why traditional clove preservation tends to use it as a heavy seasoning of already-strongly-flavored dishes rather than as a neutral preservative.

Back to Table of Contents

Membrane Disruption — The Universal Mechanism

The broad spectrum of eugenol's antimicrobial activity is explained by a non-specific mechanism: direct disruption of microbial cell membranes. Eugenol's structure (a small phenolic molecule with a hydrophobic aromatic ring, a hydrogen-bonding hydroxyl, and a methoxy and allyl substituent) is ideal for partitioning into the lipid bilayer of cell membranes. Once embedded, eugenol:

  1. Increases membrane permeability — disrupting the tight packing of phospholipids and allowing leakage of small ions (K+, Na+) and metabolites (amino acids, nucleotides) out of the cell.
  2. Dissipates proton-motive force — the transmembrane electrochemical gradient that drives adenosine triphosphate (ATP) synthesis. Without the proton gradient, the cell cannot generate the adenosine triphosphate needed for active transport, protein synthesis, or basic metabolism.
  3. Disrupts membrane-embedded enzyme function — including the electron transport chain components and the membrane ATPase.
  4. At higher concentrations, causes membrane lysis — complete cell death through loss of membrane integrity.

This mechanism is universal across bacteria (Gram-positive and Gram-negative), fungi, and enveloped viruses, all of which depend on intact phospholipid membranes for their structural integrity. It does not affect non-enveloped viruses (no membrane to disrupt) or, importantly, bacterial spores (the spore coat is not a standard membrane). It also has limited effect on intracellular pathogens once they are inside human cells, because eugenol distributes preferentially to lipid phases and may not reach intracellular pathogen concentrations sufficient for activity.

The non-specificity of the mechanism has two implications. The advantage: resistance is difficult to develop, because there is no single target to mutate; bacteria have not evolved meaningful eugenol resistance after thousands of years of human exposure, in contrast to the rapid resistance seen against most specific-target antibiotics. The disadvantage: at concentrations high enough to kill pathogens efficiently, eugenol also disrupts human cell membranes, producing the mucosal irritation and the cytotoxicity seen with high-dose essential oil application.

Back to Table of Contents

Gram-Positive Bacteria — Staphylococcus, Streptococcus, Listeria

Gram-positive bacteria have a thick peptidoglycan cell wall outside the cytoplasmic membrane. The peptidoglycan is permeable to eugenol, which reaches and disrupts the underlying membrane. Reported minimum inhibitory concentration (MIC) values for eugenol against major Gram-positive pathogens:

The methicillin-resistant Staphylococcus aureus activity is of particular interest. Methicillin-resistant Staphylococcus aureus infection has been a leading hospital-acquired infection for the past two decades, with limited and increasingly toxic antibiotic options. Clove essential oil at sub-MIC concentrations also demonstrably reverses the methicillin resistance phenotype in some methicillin-resistant Staphylococcus aureus strains, restoring susceptibility to standard beta-lactams — though this is a research finding rather than a clinical protocol. See our Staphylococcus Aureus page for more on methicillin-resistant Staphylococcus aureus.

Back to Table of Contents

Gram-Negative Bacteria — E. coli, Salmonella, Pseudomonas

Gram-negative bacteria have an additional outer membrane outside the peptidoglycan layer, which acts as a permeability barrier to many antibiotics and hydrophobic compounds. Eugenol's activity against Gram-negative bacteria is generally somewhat lower than against Gram-positives but remains clinically meaningful. Reported minimum inhibitory concentration values:

The activity against pseudomonas is of particular interest because pseudomonas biofilms are notoriously antibiotic-tolerant in clinical settings (chronic cystic fibrosis lung infection, chronic wound infection, catheter-associated infection). Eugenol shows activity not only against planktonic pseudomonas but also against established biofilms, with biofilm-disruption mechanisms discussed below.

Back to Table of Contents

Anaerobic Pathogens — Clostridium, Bacteroides, Oral Anaerobes

Strict and facultative anaerobes are a significant clinical pathogen category, including oral anaerobes that cause periodontitis, gut anaerobes that cause intra-abdominal infections after bowel surgery or perforation, and Clostridium difficile, the leading cause of antibiotic-associated diarrhea. Eugenol shows generally good activity against this category:

Spore forms of clostridial species are not affected by eugenol — this is the standard limitation of membrane-disruption mechanisms against spore-forming bacteria. Vegetative forms are killed but spores survive to germinate later. For clinical clostridium difficile management, see the C. difficile page for standard medical approach.

Back to Table of Contents

Candida and Other Fungi

Eugenol's activity against fungi is comparable in spectrum and potency to its activity against bacteria, because fungal cell membranes share the basic phospholipid architecture susceptible to eugenol disruption. The fungal cell wall (containing chitin and beta-glucans) is permeable to eugenol. Reported minimum inhibitory concentration values:

The activity against Candida is the most clinically relevant, given the common burden of recurrent candidiasis in women (vaginal), in patients with diabetes (oral and skin), and in immunocompromised hosts (systemic). Clove oil mouthwash has been studied as an adjunct in oral candidiasis (thrush), particularly in human immunodeficiency virus (HIV) patients and in patients with denture stomatitis, with reasonable benefit reported in small trials. Topical clove preparations for cutaneous candidiasis carry the same caveat as for dental use: the preparations described dilute the oil to 0.5–2% in a carrier oil, because concentrated oil irritates skin and mucous membranes.

Candida often grows as a biofilm — a slimy, protected layer that makes yeast infections hard to clear and resists standard antifungal drugs. A 2024 systematic review of clove oil against Candida albicans biofilms found 37 studies, of which only four met its criteria; it concluded that clove oil had significant anti-biofilm activity against Candida albicans and called it a promising avenue for further research.

Back to Table of Contents

Parasites — Giardia, Entamoeba, and Other Protozoa

Eugenol's antiparasitic spectrum is narrower than its antibacterial or antifungal activity but includes several clinically important targets:

The Giardia activity is the most clinically suggestive, given the substantial global burden of giardiasis (estimated 200 million symptomatic cases per year worldwide) and the rising rates of metronidazole resistance in some regions. Clinical translation is limited; standard medical therapy for giardiasis remains nitroimidazole drugs (metronidazole, tinidazole) or nitazoxanide. Clove as adjunct or alternative is research-stage rather than clinical-standard.

Back to Table of Contents

Enveloped Viruses — HSV-1, HSV-2, Influenza, Respiratory Syncytial Virus

Eugenol's antiviral activity is limited to enveloped viruses — those with a host-derived lipid envelope susceptible to the same membrane-disruption mechanism that acts on bacterial and fungal membranes. Non-enveloped viruses (norovirus, rotavirus, polio, hepatitis A) lack the lipid envelope and are not affected. Documented in vitro activity:

The Astani 2011 study in Evidence-Based Complementary and Alternative Medicine tested star anise oil and several compounds found in many essential oils (trans-anethole, eugenol, beta-eudesmol, farnesol, beta-caryophyllene and beta-caryophyllene oxide) against herpes simplex virus type 1 in cell culture. Eugenol and the related phenylpropanoids cut the virus's infectivity by about 60–80%, by directly inactivating free virus particles; among the isolated compounds, only beta-caryophyllene showed a high selectivity index (140, a measure of antiviral effect relative to harm to cells).

What is not known: the Chaieb 2007 review lists herpes simplex and hepatitis C among the viruses clove oil has been tested against, but the HSV-2, influenza and respiratory syncytial virus entries above carry no specific study citation on this page, and none of the virus entries comes from a human trial.

Back to Table of Contents

Biofilm Disruption

Biofilms — communities of bacteria embedded in a self-secreted polymer matrix — are responsible for many chronic and treatment-refractory infections including dental plaque, chronic wound infection, catheter-associated urinary tract infection, prosthetic joint infection, and chronic pseudomonas lung infection in cystic fibrosis. Biofilms are typically 10–1000-fold more resistant to standard antibiotics than the same bacterial species in planktonic (free-swimming) form, because the polymer matrix limits antibiotic penetration and the bacteria within shift to a slow-growth state that escapes most antibiotic mechanisms.

Eugenol shows several biofilm-relevant properties:

The clinical translation of biofilm-active antimicrobials is an active area of research with limited mainstream application so far. Dental use of eugenol-containing mouthwashes for plaque biofilm control is the most established clinical application; other applications (chronic wound care, urinary catheter coatings) are at the research-product stage.

Back to Table of Contents

Food Preservation Applications

Food preservation is the oldest and best-validated practical use of clove's antimicrobial activity. Beyond the historical use in tropical cuisines, modern food science has formalized several applications:

The sensory ceiling is the main practical limit. At eugenol concentrations sufficient for full antimicrobial effect, the clove flavor becomes dominant. Most food applications use clove in combination with other antimicrobial herbs and spices (thyme, oregano, cinnamon, rosemary) so that no single flavor dominates and the combined antimicrobial effect is greater than any single component alone.

Back to Table of Contents

Synergy with Other Antimicrobials

One of the most consistent findings in the eugenol antimicrobial literature is synergy with other antimicrobial compounds — both plant-derived and pharmaceutical. The synergy is documented in vitro using the checkerboard method (calculating the fractional inhibitory concentration index, FICI) and via time-kill kinetics. Notable synergies:

The mechanistic basis for synergy is typically complementary — the second compound exploits the membrane permeabilization caused by eugenol to reach intracellular targets more effectively, or addresses a different mechanism (cell wall synthesis, protein synthesis, DNA replication) that compounds the membrane disruption.

Back to Table of Contents

Cautions and Practical Limits

Back to Table of Contents

Key Research Papers

  1. Sherman PW, Billing J (1999). Darwinian gastronomy: why we use spices — spices taste good because they are good for us. BioScience 49(6):453-463. — doi:10.2307/1313553
  2. Chaieb K, Hajlaoui H, Zmantar T et al. (2007). The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytotherapy Research 21(6):501-506. — PubMed PMID: 17380552
  3. Burt S (2004). Essential oils: their antibacterial properties and potential applications in foods — a review. International Journal of Food Microbiology. — PubMed PMID: 15246235
  4. Astani A, Reichling J, Schnitzler P (2011). Screening for antiviral activities of isolated compounds from essential oils. Evidence-Based Complementary and Alternative Medicine. — PubMed PMID: 20008902
  5. Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L (2009). Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. Journal of Medical Microbiology. — PubMed PMID: 19589904
  6. Devi KP, Nisha SA, Sakthivel R, Pandian SK (2010). Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane. Journal of Ethnopharmacology. — PubMed PMID: 20435121
  7. Kuete V (2017). Medicinal Spices and Vegetables from Africa: Therapeutic Potential against Metabolic, Inflammatory, Infectious and Systemic Diseases. (Eugenol chapter). — PubMed
  8. Marchese A, Barbieri R, Coppo E et al. (2017). Antimicrobial activity of eugenol and essential oils containing eugenol: a mechanistic viewpoint. Critical Reviews in Microbiology 43(6):668-689. — PubMed PMID: 28346030
  9. Hemaiswarya S, Doble M (2009). Synergistic interaction of eugenol with antibiotics against Gram-negative bacteria. Phytomedicine. — PubMed PMID: 19540744
  10. Friedman M, Henika PR, Mandrell RE (2002). Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. Journal of Food Protection. — PubMed PMID: 12380738
  11. Machado M, Dinis AM, Salgueiro L et al. (2011). Anti-Giardia activity of Syzygium aromaticum essential oil and eugenol: effects on growth, viability, adherence and ultrastructure. Experimental Parasitology 127(4):732-739. — PubMed PMID: 21272580
  12. Sangeeta JP, Aishwarya OB, Omkar DB, Madhura NB (2024). Anti-biofilm effect of clove oil against Candida albicans: a systematic review. Journal of Oral and Maxillofacial Pathology 28(4):665-671. — PubMed PMID: 39949693
  13. Janes SE, Price CS, Thomas D (2005). Essential oil poisoning: N-acetylcysteine for eugenol-induced hepatic failure and analysis of a national database. European Journal of Pediatrics 164(8):520-522. — PubMed PMID: 15895251

PubMed Topic Searches

  1. PubMed: Clove eugenol broad-spectrum antimicrobial
  2. PubMed: Clove essential oil and Candida
  3. PubMed: Eugenol MRSA and VRE
  4. PubMed: Clove food preservation
  5. PubMed: Eugenol biofilm disruption

Back to Table of Contents

Connections

Back to Table of Contents